Altered gut microbiome composition in nontreated plaque psoriasis patients/Experiment 5

From BugSigDB


Reviewed Marked as Reviewed by Svetlana up on 2025-4-7

Curated date: 2025/04/01

Curator: Anne-mariesharp

Revision editor(s): Anne-mariesharp

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Psoriasis vulgaris plaque psoriasis,Psoriasis vulgaris,psoriasis vulgaris
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Healthy controls
Group 1 name Corresponds to the case (exposed) group for case-control studies
Psoriasis vulgaris
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients diagnosed with Psoriasis vulgaris by two attending dermatologists.
Group 0 sample size Number of subjects in the control (unexposed) group
15
Group 1 sample size Number of subjects in the case (exposed) group
32
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
6 months

Lab analysis

Sequencing type
WMS
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
Not specified
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
Mann-Whitney (Wilcoxon)
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes
Matched on Factors on which subjects have been matched on in a case-control study
age, body mass index, race, sex

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Richness Number of species
unchanged

Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2025-4-7

Curated date: 2025/04/01

Curator: Anne-mariesharp

Revision editor(s): Anne-mariesharp

Source: Fig 4d

Description: Boxplot showing the difference of the relative abundance at the phylum level between psoriatic and healthy controls samples

Abundance in Group 1: increased abundance in Psoriasis vulgaris

NCBI Quality ControlLinks
Bacteroidota

Revision editor(s): Anne-mariesharp

Signature 2

Reviewed Marked as Reviewed by Svetlana up on 2025-4-7

Curated date: 2025/04/01

Curator: Anne-mariesharp

Revision editor(s): Anne-mariesharp

Source: Fig 4d - f

Description: Boxplot showing the difference of the relative abundance at the phylum, genus and species level between psoriatic and healthy controls samples

Abundance in Group 1: decreased abundance in Psoriasis vulgaris

NCBI Quality ControlLinks
Bacillota
Coprococcus
Eubacterium
Lachnospira eligens
Lachnospiraceae bacterium 8_1_57FAA
Phocaeicola coprophilus
Roseburia
Roseburia intestinalis

Revision editor(s): Anne-mariesharp